Suscribirse

Factors associated with uncontrolled severe asthma in the biologic era - 02/01/25

Doi : 10.1016/j.rmed.2024.107881 
Hideki Yasui a, b, , Kyohei Oishi a , Fumiya Nihashi a, g , Kazuki Furuhashi a , Tomoyuki Fujisawa a , Yusuke Inoue a , Masato Karayama a , Hironao Hozumi a , Yuzo Suzuki a , Noriyuki Enomoto a , Suguru Kojima a, c , Mitsuru Niwa d , Masanori Harada e , Masato Kato f , Dai Hashimoto g , Koshi Yokomura h , Naoki Koshimizu i , Mikio Toyoshima j , Masahiro Shirai k , Toshihiro Shirai l , Naoki Inui a, b, m , Takafumi Suda a
a Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan 
b Center for Clinical Research, Hamamatsu University Hospital, Hamamatsu, Japan 
c Department of Respiratory Medicine, Shizuoka City Shizuoka Hospital, Shizuoka, Japan 
d Department of Respiratory Medicine, Hamamatsu Medical Center, Hamamatsu, Japan 
e Department of Respiratory Medicine, Iwata City Hospital, Iwata, Japan 
f Department of Respiratory Medicine, Enshu Hospital, Hamamatsu, Japan 
g Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan 
h Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan 
i Department of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan 
j Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan 
k Department of Respiratory Medicine, Tenryu Hospital, Hamamatsu, Japan 
l Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan 
m Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan 

Corresponding author. Hamamatsu University School of Medicine 1-20-1 Handayama, Chuo-ku, Hamamatsu, Shizuoka, 431-3192, Japan.Hamamatsu University School of Medicine1-20-1 HandayamaChuo-kuHamamatsuShizuoka431-3192Japan

Abstract

Background

Despite the development of biologics for severe asthma, individuals with uncontrolled status persist, posing a significant social problem. This multicenter prospective study aimed to identify factors associated with the uncontrolled status of patients with severe asthma in the biologic era assessed using the Asthma Control Questionnaire (ACQ).

Methods

Subjects with severe asthma diagnosed by respiratory specialists were enrolled from 11 hospitals. Clinical data and questionnaires were collected. We compared controlled (ACQ-5 <1.5) with uncontrolled severe asthma (ACQ-5 ≥1.5) and assessed factors linked to uncontrolled severe asthma using logistic regression analysis.

Results

One hundred fifty-four patients were analyzed (median age, 66 years; 62.3 % female; 52.6 % administered biologics). Among them, 56 patients (36.4 %) had uncontrolled severe asthma (ACQ-5 ≥1.5). The uncontrolled group had more frequent exacerbations (≥2 times in the previous year) and elevated blood neutrophil counts compared with the controlled group. Factors associated with uncontrolled status were analyzed in the overall population, with patients stratified into two groups: those receiving biologics and those not receiving biologics. Multivariate analysis revealed that frequent exacerbations and elevated blood neutrophil counts were associated with uncontrolled status in the overall population and in patients without biologics, whereas elevated blood neutrophil counts were significantly associated with uncontrolled status in patients receiving biologics.

Conclusion

Elevated blood neutrophil counts and frequent exacerbations were independently associated with uncontrolled severe asthma. Specifically, elevated blood neutrophil counts were a significant factor related to uncontrolled status irrespective of biologics, suggesting their potential utility as a biomarker in the biologic era.

El texto completo de este artículo está disponible en PDF.

Highlights

Almost half of the patients in this severe asthma cohort were treated with biologics.
Fifty-six patients (36.4 %) had uncontrolled severe asthma (ACQ-5 ≥1.5) in this study.
Frequent exacerbations and elevated blood neutrophil counts were linked to uncontrolled asthma.
Elevated blood neutrophil counts were linked to uncontrolled, irrespective of biologics.

El texto completo de este artículo está disponible en PDF.

Keywords : Asthma Control Questionnaire (ACQ), Biologic era, Blood neutrophil counts, Severe asthma, Uncontrolled


Esquema


© 2024  Elsevier Ltd. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 236

Artículo 107881- janvier 2025 Regresar al número
Artículo precedente Artículo precedente
  • Risk factors for intensive care admission in childhood patients with COVID-19 - Results of the German nationwide inpatient sample
  • Karsten Keller, Ingo Sagoschen, Volker H. Schmitt, Visvakanth Sivanathan, Ioannis T. Farmakis, Omar Hahad, Sebastian Koelmel, Frank P. Schmidt, Christine Espinola-Klein, Stavros Konstantinides, Thomas Münzel, Philipp Lurz, Lukas Hobohm
| Artículo siguiente Artículo siguiente
  • Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis
  • Ada E.M. Bloem, Hanneke M. Dolk, Anne E. Wind, Joanne J. van der Vis, Maarten J. Kampen, Jan W.H. Custers, Martijn A. Spruit, Marcel Veltkamp

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.